Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

European Union
Merck, Sharp & Dohme BV v Belgian State (C-245/03)
Judgment
The question referred to the Court
The consequences of exceeding the time…
31

Merck, Sharp & Dohme BV v Belgian State (C-245/03)

Judgment of 20 Jan 2005law://eu/cjeu/2003/c-245-03/para_31@2026-11-10

31It should be noted that where the Directive means to penalise failure to observe a time-limit by automatic acceptance of the application, it expressly states so.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Court: Court of Justice · Second Chamber
Case: C-245/03 · ECLI:EU:C:2005:41
Decided: 20 Jan 2005
Procedure: Preliminary reference
Applicant: Merck, Sharp & Dohme BV
Defendant: État belge
Rapporteur: R. Silva de Lapuerta
Advocate General: A. Tizzano
Bench: 5 judges
C.W.A. Timmermans, R. Silva de Lapuerta, C. Gulmann, R. Schintgen, G. Arestis
Language: French
Official: CURIA · EUR-Lex 62003CJ0245

Topics

Approximation of laws

History · 1 version

20 Jan 2005Reading

Connections

Interprets 1: Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems
Cited by 8: The Queen, on the application of Association of the British Pharmaceutical Industry v Medicines and Healthcare Products Regulatory Agency (C-62/09)2 provisions; Republic of Poland v European Commission (T-366/17); Republic of Poland v European Commission (T-316/15); Republic of Poland v European Commission (T-402/15)2 provisions; Republic of Cyprus v Commission of the European Communities (T-300/05); A. Menarini Industrie Farmaceutiche Riunite Srl and Others v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA), Sanofi Aventis SpA v Agenzia Italiana del Farmaco (AIFA), IFB Stroder Srl v Agenzia Italiana del Farmaco (AIFA), Schering Plough SpA v Agenzia Italiana del Farmaco (AIFA), Bayer SpA v Agenzia Italiana del Farmaco (AIFA) and Ministero della Salute, Simesa SpA v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA), Abbott SpA v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA), Baxter SpA v Agenzia Italiana del Farmaco (AIFA) and SALF SpA v Agenzia Italiana del Farmaco (AIFA) and Ministero della Salute (C-352/07); Shanghai Excell M&E Enterprise Co. Ltd and Shanghai Adeptech Precision Co. Ltd v Council of the European Union (T-299/05); Commission of the European Communities v Republic of Austria (C-311/07)
Cites 9: Commission of the European Communities v Italian Republic (C-129/00); Sodemare SA, Anni Azzurri Holding SpA and Anni Azzurri Rezzato Srl v Regione Lombardia (C-70/95); Commission of the European Communities v République de Finlande (C-229/00); Grundig Italiana SpA v Ministero delle Finanze (C-255/00); Una Coonan v Insurance Officer (110/79); Duphar BV and others v The Netherlands State (238/82); Fritz Stöber and José Manuel Piosa Pereira v Bundesanstalt für Arbeit (C-4/95, C-5/95); Elissavet Paraschi v Landesversicherungsanstalt Württemberg (C-349/87); Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems